AIM Encourages Collaboration & Investment in Immunization and Emergency Preparedness Programs to Prepare for Next Pandemic
IOM Report on Adverse Effects of Vaccines
Landmark 2011 report created in response to Health Resources and Services Administration request to the IOM to review a list of adverse events associated with eight vaccines—varicella zoster, influenza (except 2009 H1N1), hepatitis B, HPV, MMR, hepatitis A, meningococcal, and…
Using ARRA Funds to Implement Strategies to Improve Immunization Coverage Rates
The American Recovery and Reinvestment Act (ARRA) provided approximately $97 million to support immunization program operations and infrastructure. The funding provided an opportunity for state, territorial and urban area grantees to implement new strategies to increase vaccinations in various populations.…
VFC Influenza Vaccine Distribution
AIM conducted a survey of members to see the percentage of overall influenza allocation received by each grantee as of 10/14/2011.
Impact of Population Estimation Survey (PES) Changes on Immunization Programs
In the summer of 2008 CDC implemented methodological changes to the PES, the tool used by CDC to allocate vaccine funding to grantees. AIM conducted a survey to explore the impact of the PES changes. Data was utilized by the…
Recommendations for Vaccine Shortage/Influenza Vaccine Management in Centralized Distribution System
2008: Role of Public Health Clinics Vaccinating the Underinsured
AIM conducted a survey of members to explore the role of public health clinics (excluding FQHCs, RHCs, and public health clinics which are deputized as FQHCs or RHCs) in vaccinating underinsured and the number of underinsured children served by those…